Evidence map›Paper›PMID 30636939›Full record

ArticleJOP : Journal of the pancreas2018

An Appraisal of Current Guidelines for Managing Malignancy in Pancreatic Intraductal Papillary Mucinous Neoplasm.

Kazuki Takakura, Yuichi Torisu, Yuji Kinoshita, Yoichi Tomita, Masanori Nakano, Tsunekazu Oikawa, Shintaro Tsukinaga, Kazuki Sumiyama, Guido Eibl, Masayuki Saruta

Abstract read
PubMed Full text at PMC
In one paragraph

Article in JOP : Journal of the pancreas, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Kazuki TakakuraDivision of Gastroenterology and Hepatology, Department of Internal Medicine.
Yuichi TorisuDivision of Gastroenterology and Hepatology, Department of Internal Medicine.
Yuji KinoshitaDivision of Gastroenterology and Hepatology, Department of Internal Medicine.
Yoichi TomitaDivision of Gastroenterology and Hepatology, Department of Internal Medicine.
Masanori NakanoDivision of Gastroenterology and Hepatology, Department of Internal Medicine.
Tsunekazu OikawaDivision of Gastroenterology and Hepatology, Department of Internal Medicine.
Shintaro TsukinagaDepartment of Endoscopy, The Jikei University School of Medicine, Tokyo, Japan.
Kazuki SumiyamaDepartment of Endoscopy, The Jikei University School of Medicine, Tokyo, Japan.
Guido EiblDepartment of Surgery, David Geffen School of Medicine, University of California at Los Angeles, USA.
Masayuki SarutaDivision of Gastroenterology and Hepatology, Department of Internal Medicine.
Jikei University School of Medicine · JPUniversity of California, Los Angeles · US

Funding

Targeting diet-induced promotion of Kras-initiated pancreatic adenocarcinomaP01CA163200 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PANDOL, STEPHEN J. · 2012 to 2016
$6.2M
NCI NIH HHS P01 CA163200
6 · The paper itself

Abstract

Pancreatic intraductal papillary mucinous neoplasm was originally regarded as a benign mucinous cystic tumor but certainly has a marked malignant potential. With the array of high-resolution imaging modalities that are now available, more frequent incidental asymptomatic intraductal papillary mucinous neoplasm patients can be diagnosed. Until now, our clinicians have been managing intraductal papillary mucinous neoplasm patients by referring to the international consensus guidelines which have been revised twice or American Gastroenterological Association guidelines. The aim of this review is to reassess the current guidelines for the management of malignancy in intraductal papillary mucinous neoplasm. Furthermore, we specifically discuss the problems to be solved for establishing more refined guideline for the early detection, risk stratification and better management of pancreatic cancer in intraductal papillary mucinous neoplasm patients.

Indexed as

EndosonographyGuidelinePancreatic Neoplasms

Identifiers

PMID30636939
PMCPMC6327957
OpenAlexW2897015858

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.